ORAMED PHARMACEUTICALS INC. 10-K Cybersecurity GRC - 2024-03-06

Page last updated on April 11, 2024

ORAMED PHARMACEUTICALS INC. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-03-06 17:00:35 EST.

Filings

10-K filed on 2024-03-06

ORAMED PHARMACEUTICALS INC. filed an 10-K at 2024-03-06 17:00:35 EST
Accession Number: 0001213900-24-020485

Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!

Item 1C. Cybersecurity.

ITEM 1C. CYBERSECURITY. The Board recognizes the critical importance of maintaining the trust and confidence of our business partners, employees and clinical trial participants. The Audit Committee is responsible for reviewing our policies with respect to cybersecurity risks and relevant contingent liabilities and risks that may be material to the Company, including risks from third parties and business partners. We generally seek to address cybersecurity risks by implementing security measures on our internal computer systems and ensuring that third parties and business partners implement similar measures. These security measures include firewalls, intrusion prevention and detection systems, anti-malware functionality and access controls, which are evaluated by our external IT consultant and improved through vulnerability assessments and cybersecurity threat intelligence. Our Chief Operating and Business Officer is responsible for implementing protection measures for our information systems from cybersecurity threats and promptly responding to any cybersecurity incidents. To date, risks from cybersecurity threats have not materially affected us and we do not currently believe any risks from cybersecurity threats are reasonably likely to affect the Company, including our business strategy, results of operations or financial condition. For further information, see Item 1A. Risk Factors, under Our business and operations would suffer in the event of computer system failures, cyber-attacks or deficiencies in our cyber-security.


Company Information

NameORAMED PHARMACEUTICALS INC.
CIK0001176309
SIC DescriptionPharmaceutical Preparations
TickerORMP - Nasdaq
Website
CategoryNon-accelerated filer
Smaller reporting company
Fiscal Year EndDecember 30